A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Mibg


Molecular Insight Pharmaceuticals, Inc. Initiates Azedra(TM ...  -  May 10, 2007
PipelineReview.com (press release),While I-131-MIBG containing cold contaminants is commercially available in Europe for therapeutic use, it is not approved in the United States,

Current Treatment of Malignant Pheochromocytoma  -  Apr 4, 2007
Journal of Clinical Endocrinology and Metabolism,Similar to cytotoxic chemotherapy with cyclophosphamide, vincristine, and dacarbazine, MIBG can induce remission for a limited period in a significant

AnazaoHealth Teddy Bears are 'Making It Bearable For Kids™'  -  Mar 22, 2007
SocialFunds.comToday, the company is proud to announce a new program for the littlest patients in hospitals receiving I-123 MIBG, a preparation, used primarily to

Targeted Isotope Therapy Effective for Refractory Neuroblastoma  -  Mar 21, 2007
Cancer Consultants (press release),Researchers from the Universities of California at San Francisco, Pennsylvania and Michigan have reported that Iodine-131-metaiodobenzylguanidine (MIBG) is

Biotech IPO Watch: Molecular Insight Seeks Imaging and ...  -  Feb 4, 2007
Seeking Alpha,Azedra, which was previously known as Ultratrace MIBG or I-131-metaiodobenzylguanidine, is aimed at metastatic neuroendocrine tumors.

Childhood Cancer Combatted During St. Baldrick's Day  -  Feb 21, 2007
Westport-News,Dana-Farber/Children's Hospital Cancer Care (DFCHCC), and director of the Neuroblastoma Program, to open a targeted MIBG/radiotherapy program at DFCHCC.

DRAXIS Posts Record Earnings and Cash Flow for 2006  -  Feb 8, 2007
CNW Telbec (Communiqués de presse),Completion of clinical trials for I-131 MIBG for the diagnosis and treatment of neuroblastoma and related malignancies and its subsequent sale and

Molecular Insight Prices $70M IPO For Radiotherapeutics  -  Feb 4, 2007
BioWorld Online,Azedra, an MIBG molecule that's been radiolabeled with the Ultratrace technology, is expected to begin a Phase I/II trial in adults in the first half of

SNM Examines Molecular Imaging’s Power To Detect, Treat Diseases  -  Jan 6, 2007
Medical News Today (press release),Applications in Vascular Molecular Imaging," "The Biology of Imaging of Neuroblastoma," "High-Dose I-131 MIBG Therapy in Children," "Low-Dose I-131 MIBG

SNM Examines Molecular Imaging's Power to Detect, Treat Diseases  -  Jan 10, 2007
DOTmed.com (press release),...advances in cardiovascular and brain molecular imaging, MIBG therapy in children and adults, clinical brain imaging and nuclear medicine technology,


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional